CQC compliant infection control baths to help care homes and hospitals
At June’s Health Plus Care event, Gainsborough Specialist Bathing showcased its new antimicrobial technology for baths, delivering CQC compliant infection control and aiming to reduce bather and carer illness.
The control of healthcare-associated infections (HCAIs) remains a major challenge for care homes and hospitals and involves employing a combination of infection prevention and control strategies.
Through the integration of BioCote silver-ion technology during manufacture, Gainsborough baths now provide 99.99% protection against Influenza H1N1, E.coli, salmonella and antibiotic resistant ‘superbugs’ such as CRO, CRE, VRE and MRSA.
Dangerous microbes cannot survive on treated bathing materials, so bather and carer illness are reduced and care performance is enhanced according to Gainsborough Specialist Bathing.
Resulting in CQC compliance, the Biocote technology is already providing a significant advantage to many leading care home groups in its assisted bathing solutions says the company.
Luke Torkington, Four Seasons Health Care, commented: “BioCote is vital for our care homes’ infection control process. With the increased threat from superbugs, the inclusion of BioCote technology in Gainsborough baths delivers our carers and residents a significant advantage.”
Angela Hunt, B&M Care, added that both staffs and residents can be confident as 99.9% of superbugs cannot survive on the bathing surface due to the BioCote technology.
“I have managed outbreaks of infection in previous jobs and fully appreciate the value delivered by antimicrobial protection especially during the winter months,” Angela continued.
Furthermore, clinical trials have confirmed the effectiveness of BioCote in healthcare environments. During refurbishment of a nursing home in Leicester, a study was performed to compare bathrooms where one was fitted with a range of BioCote treated antimicrobial products and another with untreated, comparable products.
The results generated by the presence of BioCote showed a 95 percent reduction in bacteria.
Similarly, two hospital outpatient units provided the environments for an 18-month pilot study. Unit A was refurbished with BioCote treated products and also a number of untreated products. A similar, refurbished outpatient ward containing untreated items (Unit B) served as a control. Again, BioCote generated a significant result with a 96 percent reduction in bacteria.
Peter Eckhardt, CEO at Gainsborough Healthcare Group, concluded: “Our unique BioCote advantage is clear to see for all.
“Through evidence-based results the presence of our treated baths, such as the market leading Gentona, significantly reduces the presence of Superbugs – hence delivering greater protection from illness, cross contamination and microbial outbreaks.
“Our customer-focused ethos is once again underlined by this innovation whilst underpinning quality care sustainability and CQC hygiene compliance.”
Part of the Gainsborough Healthcare Group, Gainsborough Specialist Bathing is a specialist in assisted baths for long term and acute care since 1988. Manufactured in Great Britain, the company’s wide-ranging portfolio has been developed in cooperation with semi-ambulant bathers, healthcare providers and moving and handling professionals.